Semnur Pharmaceuticals, Inc. Payments for Repurchase of Private Placement
Semnur Pharmaceuticals, Inc. (SMNR) reported Payments for Repurchase of Private Placement of $1.65 million for the 9-month period ending 2022-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsForRepurchaseOfPrivatePlacement · last filed 2023-11-09
- Semnur Pharmaceuticals, Inc. payments for repurchase of private placement for the quarter ending 2022-09-30 was $0.00.
| Period end | Payments for Repurchase of Private Placement 3 month | Payments for Repurchase of Private Placement 6 month | Payments for Repurchase of Private Placement 9 month |
|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $1.65M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $1.65M 10-Q · filed 2023-08-15 |